|Podcasts|August 12, 2021
Managed Care Cast Presents: MS Stakeholder Summit—New Treatment Landscape in MS, Part 1
In part 1 of this 2-part podcast, a panel of experts discusses tailoring treatments to patients with multiple sclerosis (MS), payer considerations, and more.
Advertisement
Today, we are bringing you part 1 of a 2-part sponsored podcast series discussing new treatments in multiple sclerosis (MS). In part 1, a panel of experts discusses tailoring treatments to patients with MS, payer considerations, and more.
Listen above or through one of these podcast services:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
4
Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making
5
